Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹5,298.00
3.50 (0.07%)
Medium VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹63.35K Cr
MID CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
26.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹4,716.2+12.3%
52W High₹5,933.5-10.7%
Current Price
₹5,298.00
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹4,238.40
Upper Circuit₹6,357.60
Reference Price
₹5,298.00
Investment Checklist
Triple Top on 1W (BREAKOUT CONFIRMED) — target ₹4834.5
Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹4834.5
Composite score -41.75 (SELL) with 84.6% confidence
Trend: Price below most MAs — downtrend
News: Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nif...
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
85%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend
EMA20
5358.6
EMA50
5403.27
EMA200
5392.4
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows4
Lower Highs4
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹5360.40
₹5469.00
₹5577.12
₹5662.00
₹5775.00
Support (Below)
₹5114.14
₹4945.00
₹4732.18
Volume Analysis
TrendDECREASING
Change-27.30%
Unusual VolumeNo
Recent MA Crossovers
20/50 Bearish Cross
4 days ago
SELL
Stop Loss Levels
Fixed Risk
1% Risk₹5245.02
3% Risk₹5139.06
5% Risk₹5033.10
7% Risk (Custom)
₹4927.14Technical Levels
1x ATR (Volatility)₹5147.77
2x ATR (Swing)₹4997.54
3x ATR (Trend)₹4847.31
Immediate Support₹5114.14
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹2,983.9 Cr | ₹3,371.1 Cr | ₹4,001 Cr | ₹3,736.8 Cr |
| Net Profit | ₹305.9 Cr | ₹664.3 Cr | ₹765.1 Cr | ₹636 Cr |
| EPS | — | ₹55.56 | ₹63.99 | ₹53.19 |
| Operating Profit | ₹502.8 Cr | ₹888.5 Cr | ₹1,024.5 Cr | ₹918.3 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 20 Feb 2026 | Interim Dividend - Rs 43 Per Share | INTERIM_DIVIDEND |
| 08 Aug 2025 | Dividend - Rs 8 Per Share | DIVIDEND |
| 14 Feb 2025 | Interim Dividend - Rs 37 Per Share | INTERIM_DIVIDEND |
| 09 Aug 2024 | Dividend - Rs 5 Per Share | DIVIDEND |
| 16 Feb 2024 | Interim Dividend - Rs 35 Per Share | INTERIM_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ALKEM
View All
positive
Google News - India Markets 5d ago
Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a row - Mint
Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a rowMint
ABSLBANETFABSLNN50ETABSLPSEALKEMAONETMMQ50AONETOTALBSLNIFTYHEALTHYMOCAPITALMOMENTUMNIFTYQLITYPHARMABEESSPARCTECHFinancial ServicesHealthcare
positive
ET Markets - Stocks 10d ago
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal
Shares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece on Tuesday. Promoter-linked entities offloaded their stake, while domestic mutual funds and foreign institutional investors emerged as key buyers, signalling strong institutional participation. The company also launched semaglutide pre-filled syringes in India.
ALKEMALPHAETFEQUAL200FOCUSGOLD1GOLDBETAGROWWN200HDFCGOLDLICNETFSENMIDCAPBETAMOM30IETFMOMENTUMMOMENTUM30MOMOMENTUMNEXT50BETANIFTYQLITYSILVERBETASTANLEYTATAGOLDTATSILVTNIDETFConsumer DurablesFinancial Services
neutral
Business Standard - Markets 10d ago
Stocks to Watch, June 3: Alkem Labs, Dhanuka Agritech, Paytm, Canara Bank
Stocks to Watch today, June 3: Infosys, Alkem Labs, Paytm among others in focus; here's why
AGRITECHALKEMBANKINDIACANBKDHANUKAFOCUSINFYPAYTMChemicalsConsumer Durables